1 – 7 of 7
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Acceptable performance of blood biomarker tests of amyloid pathology — recommendations from the Global CEO Initiative on Alzheimer’s Disease
(
- Contribution to journal › Article
- 2022
-
Mark
Performance of αSynuclein RT-QuIC in relation to neuropathological staging of Lewy body disease
(
- Contribution to journal › Article
- 2020
-
Mark
Maximizing Safety in the Conduct of Alzheimer's Disease Fluid Biomarker Research in the Era of COVID-19
(
- Contribution to journal › Letter
- 2018
-
Mark
Investigating the genetic architecture of dementia with Lewy bodies : a two-stage genome-wide association study
(
- Contribution to journal › Article
- 2017
-
Mark
Analysis of C9orf72 repeat expansions in a large international cohort of dementia with Lewy bodies
(
- Contribution to journal › Article
- 2010
-
Mark
Distinct cerebrospinal fluid amyloid beta peptide signatures in sporadic and PSEN1 A431E-associated familial Alzheimer's disease
(
- Contribution to journal › Article
- 2007
-
Mark
Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins
(
- Contribution to journal › Article